23andMe Board Quits As CEO Of DNA Testing Company Plans To Go Private
The board of directors for 23andMe quit following disagreements over the CEO's plans to privatize the DNA testing company.
23andMe directors resign as CEO seeks to take genetic-testing company private
All of 23andMe's independent directors have resigned from its board in a rare move that marks the latest challenge for the genetic-testing company.
Independent Directors of 23andMe Resign from Board
The independent directors of the Board of 23andMe Holding Co. (Nasdaq: ME), today sent the following letter to Anne Wojcicki, Chief Executive Officer, Co-Founder, and Chair of the Board of Directors of 23andMe,
23andMe independent directors quit board over unsatisfactory buyout plan from CEO
The independent directors of genetic testing firm 23andMe said on Tuesday they have resigned from the company's board after not receiving a satisfactory take-private offer from CEO Anne Wojcicki.
23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private
All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the company private since April, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share, in July.
Independent directors resign from 23andMe board after opposing move to privatize
The seven independent members of the board of personal genomics company 23andMe quit Tuesday amid opposition to CEO Anne Wojcicki’s plan to take the company private.
23andMe directors resign as the CEO of the genetic-testing company seeks to take it private
All of 23andMe's independent directors resigned from its board this week, a rare move that marks the latest challenge for the genetic-testing company. The resignations follow drawn-out negotiations with 23andMe CEO and co-founder Anne Wojcicki,
Directors Resign as 23andMe Privatization Efforts Sputter
Board memebers quit as founder Anne Wojcicki works to come up with an acceptable financial offer to purchase its remaining shares and take the company private.
23andMe Directors Resign as CEO Anne Wojcicki Pursues Plans to Take Company Private
Independent directors of 23andMe resign as CEO Anne Wojcicki aims to take the genetic-testing company private, citing governance concerns.
Read the memo 23andMe's cofounder sent to staff after the entire board quit
Me's entire board of directors resigned over cofounder and CEO Anne Wojcicki's ongoing plan to take it private.
Rolling Out13h
23andMe’s board resignation: Money problems and ties to the Black community
On Sept. 23, the board of directors at 23andMe, a prominent DNA testing company, announced their resignation following a series of disagreements with CEO Ann ...
23andMe sees independent board directors quit en masse
Me, the personal genomics company, went public in early 2021 via a merger with a blank check company that valued it at $3.5 ...
ME STOCK ALERT: 23andMe Holding Co. Shareholders are Encouraged to Contact BFA Law About Investigation into the Company's Board of Directors
By letter dated August 2, 2024, a Special Committee of the Board of Directors of 23andMe rejected that offer, noting that it "provide [d] no premium to the closing price per share on Wednesday, July ...
23andMe Shares Fall After Independent Directors Resign Amid Spat Over Buyout Bid
23andMe shares dropped on Wednesday following the resignation of independent directors amid a clash with Chief Executive Anne Wojcicki regarding her intentions to take the company private. Shares in ...